Rosetta Genomics offers MicroRNA-based mesothelioma diagnostic test

"Press Release from Rosette Genomics
Rosetta Genomics Announces Commercial Availability of Its Third MicroRNA-BasedDiagnostic Test: miRview(TM) meso
read more" (2008-12-31)
Read more...